A tumor metabolome panel identifies altered cell states that lead to drug tolerance.

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

Meet some of the people featured in the July/August 2019 issue of The Scientist.

Not only can artificial intelligence revolutionize healthcare, it could help restore the doctor-patient relationship.

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

Eric Topol, founder and director of Scripps Research Translational Institute and Reading Frames author, discusses the future of the doctor-patient bond in an era of artificial intelligence–driven medicine.

This month’s Profilee, Dana-Farber Cancer Institute researcher Stuart Orkin, talks about treating kids with cancer and other blood disorders.

Comparing the cells of cancer patients who did and did not respond to the immunotherapy could reveal biomarkers to predict who should receive it in the first place.

The expression of a slew of genes in psychiatric patients closely tracks pain intensity and predicts future emergency room visits, according to a study.

See how a computational pipeline uses next-generation sequencing data to identify genetic alterations that produce cancer-specific antigens.

The field is young, but predicting antigens produced by patients’ malignant cells could yield successful treatments for individuals with a range of cancer types.

There are currently more than two dozen ongoing Phase 1 and Phase 2 trials using different vaccine platforms such as DNA, RNA, synthetic long peptides, and dendritic cells.

Through their effects on metabolism and immunity, bacteria in the gut affect whether medications will be effective for a given patient.

The agency says it has taken various steps to ensure the privacy of participants’ data. 

The nationwide experiment will initially include around 100,000 volunteers.

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

Zebrafish larvae transplanted with patients’ tumors respond as their human donors do to chemotherapy.